vaccine manufacturers

Top 3 Sparks of Interest for Leading Vaccine Academics

Recently we undertook the research for the 15th annual World Vaccine Congress. As part of that research, we spoke to leading vaccine academics from the likes of University of Oxford and Erasmus MC to find out what they thought were the most interesting trends in industry at the moment. These were the top 3: 1. The renaissance of veterinary vaccines …

Vaccine Asia

Vaccine Asia Live: Overcoming the Challenges of Vaccine Trials to Address the Growing Demand in Asia

Seeing the great importance of vaccine development in Asia due to its great demand, it is pertinent that any challenges in vaccine development be addressed, especially in vaccine clinical trials. To help address these challenges, Dr Teoh Yee Leong, CEO of Singapore Clinical Research Institute(SCRI) , spoke about what these challenges were and advice on how to overcome them. Singapore …

Vaccine Asia Live: Forging Partnerships for Improved Immunisation in Laos

“Vaccination as the most cost-efficient method to save millions of lives around the world.” To kick-start the 2nd day’s activities for World Vaccine Congress Asia 2014, we have the privilege and honour in having Dr Bounkong Syhavong, the Vice Minister of Health for Lao People’s Democratic Republic to present on the forging of partnerships for improved immunisation in Laos. For the …

Vaccine

Vaccine Asia Live: Novel Vaccines for Emerging Diseases

Most vaccines developed target infectious diseases and cancer, with cancer vaccines being listed more under therapeutic vaccines. To enlighten us on vaccines for infectious diseases, Ms Zhang Xiaoshu, Director of Business Development at BravoBio, China, presented on the topic of Novel Vaccines for Emerging Diseases. BravoBio was founded in 2011 with its  headquarters in Shanghai and multiple sites in China. …

Vaccine Asia Live: Forging Strategic Partnership for R&D to Meet High Demands for Vaccines in Asia

As a unique feature of Terrapinn conferences, the roundtable discussions serve as an interactive platform for meaningful discussion. At World Vaccine Congress Asia 2014, Do Tuan Dat, President & General Director of Vabiotech, Vietnam, moderated the discussion on the topic of “Forging Strategic Partnership for R&D to Meet High Demands for Vaccines in Asia”. A consensus was reached among the …

Vaccine Asia Live: Accelerating Vaccine Development in Asia through Public-Private Partnership(PPP)

Live at World Vaccine Congress Asia 2014, the day was opened with a panel discussion on accelerating vaccine deelopment in Asia through Public-Private Partnerships(PPP). Andrew Potter, CEO of PREVENT Canada moderated the discussion with Lanling Zou of NIAID USA, Duane Gubler of SUKW-NUS Graduate Medical School Singapore  and Stephen Cook of GSK Belgium. It was a great start to a …

Manufacturing Technology Transfer from EU to India: example JE (Japanese Encephalitis) vaccine

In November 2012 over 200 delegates participated in the 13th Annual World Vaccine Congress Lyon in France. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Dr. Goetz Reiner – Vice President, Bulk Manufacturing, Biological E. Limited, entitled: ‘Manufacturing Technology …

GSK seeks partner in China for joint venture on vaccines

A rising population and an expanding immunization schedule makes China an attractive prospect for vaccine manufacturers, and now the largest vaccine manufacturer of them all, GlaxoSmithKline (GSK), is eyeing up the potential for a joint venture in the country.  "We are keen to find a partner in China," Christophe Weber, head of the company's vaccines unit, told Bloomberg. Over the …